What Should Not Be Taken Together with Omega-3?

Omega-3 fatty acids (EPA and DHA) offer well-documented benefits for cardiovascular and neurological health, but they can interact with certain medications and supplements. Understanding these interactions helps minimize risks such as excessive bleeding, hypotension, or altered drug efficacy.

Key interactions to know

Major concerns center on three pathways: effects on blood clotting, blood pressure modulation, and potential impacts on drug metabolism. The most clinically relevant interactions include:

• Anticoagulants and antiplatelet drugs: Medications such as warfarin, clopidogrel, aspirin and heparin reduce clot formation. Omega-3s have mild antiplatelet effects and can, in some cases, enhance anticoagulation. This may raise bleeding risk—manifesting as easy bruising, nosebleeds or prolonged bleeding from minor cuts.
• Blood pressure medications: Omega-3s can modestly lower blood pressure. When combined with ACE inhibitors, beta-blockers, ARBs or calcium channel blockers, they may contribute to symptomatic hypotension (dizziness, lightheadedness).
• High-dose antioxidants (e.g., Vitamin E): Very high doses of Vitamin E (>300 mg/day is often cited as a tolerable upper intake level) are associated with impaired platelet aggregation and increased bleeding tendency. Combined high-dose Vitamin E and Omega-3 supplementation should be managed carefully.

Sources and cumulative intake

Taking multiple Omega-3 sources (fish oil supplements plus regular consumption of fatty fish or fortified foods) can lead to higher-than-intended intake. The European Food Safety Authority has referenced up to 5 g/day of combined EPA and DHA as an upper bound for adults in research contexts, but typical supplemental doses are much lower. Track dietary and supplemental sources to avoid cumulative excess and gastrointestinal side effects such as nausea or loose stools.

Practical guidance

If you take blood thinners, begin Omega-3s only after consulting your clinician and expect monitoring such as INR testing if on warfarin. For blood pressure management, check readings regularly when starting Omega-3s and report any dizziness or fainting. Avoid initiating high-dose Vitamin E alongside Omega-3 without medical advice.

If you are preparing for surgery, discuss temporary discontinuation of Omega-3 supplements with your care team because of bleeding risk. Maintain consistent supplement routines rather than intermittent dosing to reduce variability in effects.

Further reading and resources

For a focused discussion on precautions and clinical considerations, see this article explaining what should not be taken with Omega-3. To compare different Omega-3 formulations and considerations for selection, consult the guide on which omega-3 is better. For a broader overview of supplement interactions, the piece on which dietary supplements don't go together is useful, and a concise external summary of interactions is available at this supplement interaction overview.

When in doubt, coordinate supplements with prescribers and pharmacists, monitor bleeding parameters and blood pressure as appropriate, and keep a record of all medications and supplements to inform safe, evidence-based decisions.